Comparison between angiotensin II receptor blocker and beta-blocker on blood pressure, hemodynamic, and lipid in hypertensive hypercholesterolemic patients treated with statin

被引：0
作者：
Prandin, M. G. [1 ]
Dormi, A. [1 ]
Veronesi, M. [1 ]
Bacchelli, S. [1 ]
Immordino, V. [1 ]
Ambrosioni, E. [1 ]
Borghi, C. [1 ]
机构：
[1] Univ Bologna, St Orsola Malpighi Hosp, Dept Internal Med, Bologna, Italy
来源：
JOURNAL OF HYPERTENSION | 2006年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [31] Impact of statin and angiotensin II receptor blocker use on mortality for patients hospitalized with sepsis
    Mortensen, Eric
    Restrepo, Marcos
    Copeland, Laurel
    Anzueto, Antonio
    Pugh, Jacqueline
    Pugh, Mary Jo
    CHEST, 2006, 130 (04) : 135S - 135S
  • [32] BLOOD-PRESSURE EFFECTS OF THE ANGIOTENSIN-II RECEPTOR BLOCKER, LOSARTAN
    WEBER, MA
    BYYNY, RL
    PRATT, JH
    FAISON, EP
    SNAVELY, DB
    GOLDBERG, AI
    NELSON, EB
    ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (04) : 405 - 411
  • [33] Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist
    Schiffrin, EL
    Deng, LY
    JOURNAL OF HYPERTENSION, 1996, 14 (10) : 1247 - 1255
  • [34] The combination therapy of angiotensin II receptor blocker, calcium channel blocker and β blocker is important to control blood pressure in patients with chronic phase of aortic dissection and aneurysm
    Yamagishi, Toshio
    Sekin, Yoshihito
    JOURNAL OF HYPERTENSION, 2006, 24 : 367 - 367
  • [35] Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function
    Schiffrin, EL
    Park, JB
    Pu, Q
    JOURNAL OF HYPERTENSION, 2002, 20 (01) : 71 - 78
  • [36] Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation
    Kario, Kazuomi
    Hoshide, Satoshi
    Uchiyama, Kazuaki
    Yoshida, Tetsuro
    Okazaki, Osamu
    Noshiro, Takao
    Aoki, Hirotaka
    Mizuno, Hiroyuki
    Matsumoto, Yuri
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (10) : 1036 - 1044
  • [37] Effects of Angiotensin II Type 1 Receptor Blocker on Blood Pressure Variability and Cardiovascular Remodeling in Hypertensive Patients on Chronic Peritoneal Dialysis
    Shigenaga, Atsu-ichiro
    Tamura, Kouichi
    Dejima, Toru
    Ozawa, Motoko
    Wakui, Hiromichi
    Masuda, Shin-ichiro
    Azuma, Koichi
    Tsurumi-Ikeya, Yuko
    Mitsuhashi, Hiroshi
    Okano, Yasuko
    Kokuho, Toshiharu
    Sugano, Teruyasu
    Ishigami, Tomoaki
    Toya, Yoshiyuki
    Uchino, Kazuaki
    Tokita, Yasuo
    Umemura, Satoshi
    NEPHRON CLINICAL PRACTICE, 2009, 112 (01): : C31 - C40
  • [38] Efficacy and safety of angiotensin II receptor blocker in elderly isolated systolic hypertensive patients
    Saito, Ikuo
    Kushiro, Toshio
    Sato, Yuki
    Harada, Ken-ichi
    Kobayashi, Fumiaki
    Sagawa, Kei
    Hiramatsu, Katsutoshi
    JOURNAL OF HYPERTENSION, 2006, 24 : 378 - 378
  • [39] Angiotensin II receptor blocker combined with eplerenone or hydrochlorothiazide for hypertensive patients with diabetes mellitus
    Karashima, Shigehiro
    Yoneda, Takashi
    Kometani, Mitsuhiro
    Ohe, Masashi
    Mori, Shunsuke
    Sawamura, Toshitaka
    Furukawa, Kenji
    Yamagishi, Masakazu
    Takeda, Yoshiyu
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2016, 38 (07) : 565 - 570
  • [40] Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patients
    Sardo, Maria A.
    Mandraffino, Giuseppe
    Riggio, Stefania
    D'Ascola, Angela
    Alibrandi, Angela
    Saitta, Carlo
    Imbalzano, Egidio
    Castaldo, Maria
    Cinquegrani, Maurizio
    Saitta, Antonino
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (09) : 933 - 938
12345